Scott Mendel, President & CEO at GenMark Diagnostics, Inc. (GNMK), sold 50,000 shares at $15.02 ($751K) on 2020-08-26, disclosed to the SEC on 2020-08-28.
Seasonal sale ($751k) by President & CEO — this insider has traded GNMK in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GNMK | SELL | 2021-01-25 | $1.8M | — | Filing → |
| GNMK | SELL | 2021-01-21 | $727K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |